News | May 10, 2022
Sun gets 10 observations from USFDA for Halol facility
The company is preparing the response to the observations, which will be submitted to the USFDA within 15 business days
The company is preparing the response to the observations, which will be submitted to the USFDA within 15 business days
Pfizer to commercialize NURTEC ODT (rimegepant), an innovative compound for the prevention and acute treatment of migraine, a condition with high unmet need
Takeda and United Nations Global Compact Network of India (UNGCNI) join hands
He was previously working as the CEO of IVD business at Trivitron Healthcare and drove its growth through innovation
The company enters into collaborations with leading next-generation sequencing (NGS) companies to facilitate trial enrollment for PRECISION 1, the Company’s Phase 2 registrational trial
Lupin recognized the need to digitize more applications, improve scalability, decrease risk of security breaches and eliminate critical data loss
Ahead of International Thalassemia Day on 8th May, medical professionals and representatives of patient bodies participated in a virtual discussion on the current situation of Thalassemia management in India
There is a need for the Ministry of Health to put it on the priority list and address the issues, which are numerous
This newly designed small-format detector is made up of caesium iodide technology and is extremely high in resolution, capable of capturing the fine detail of smaller anatomical structures present in paediatric patients
Novel approach driven by GN Corp Japan with potentials in neurological illnesses
Subscribe To Our Newsletter & Stay Updated
